HIV incidence among men who have sex with men after diagnosis with sexually transmitted infections

Sexually Transmitted Diseases

Volumn 43, Issue 4, 2016, Pages 249-254

  Katz, David A ^a,b   Dombrowski, Julia C ^a,b   Bell, Teal R ^c   Kerani, Roxanne P ^a,b   Golden, Matthew R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE; NITRITE;

ADULT; ARTICLE; CHLAMYDIAL URETHRITIS; CHLAMYDIASIS; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; PHARYNGITIS; RECTUM DISEASE; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE USE; SYPHILIS; URETHRITIS; ADOLESCENT; CHLAMYDIA INFECTIONS; COMPLICATION; HIV INFECTIONS; MALE HOMOSEXUALITY; MIDDLE AGED; PRE-EXPOSURE PROPHYLAXIS; RISK; SEXUALLY TRANSMITTED DISEASES; WASHINGTON; YOUNG ADULT;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; GONORRHEA; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PRE-EXPOSURE PROPHYLAXIS; RISK; SEXUALLY TRANSMITTED DISEASES; SYPHILIS; WASHINGTON; YOUNG ADULT;

EID: 84958824792     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000423     Document Type: Article

References (31)

1. Piot P, Laga M. Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIV. BMJ 1989; 298:623-624.
2. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission ofHIVinfection. Sex Transm Infect 1999; 75:3-17.
3. Ward H, Ronn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS 2010; 5:305-310.
4. Cohen CR, Plummer FA, Mugo N, et al. Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: A mechanism for enhanced HIV-1 transmission? AIDS 1999; 13:327-332.
5. de Jong MA, de Witte L, Oudhoff MJ, et al. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest 2008; 118:3440-3452.
6. Henning T, Butler K, Mitchell J, et al. Development of a rectal sexually transmitted infection-HIV coinfection model utilizing Chlamydia trachomatis and SHIVSF162p3. J Med Primatol 2014; 43:135-143.
7. Henning TR, Butler K, Hanson D, et al. Increased susceptibility tovag-inal simian/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis. J Infect Dis 2014; 210:1239-1247.
8. Kaul R, Pettengell C, Sheth PM, et al. The genital tract immune milieu: An important determinant of HIV susceptibility and secondary transmission. J Reprod Immunol 2008; 77:32-40.
9. Masson L, Mlisana K, Little F, et al. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: A cross-sectional study. Sex Transm Infect 2014; 90:580-587.
10. Ramsey KH, Schneider H, Cross AS, et al. Inflammatory cytokines produced in response to experimental human gonorrhea. J Infect Dis 1995; 172:186-191.
11. Schust DJ, Ibana JA, Buckner LR, et al. Potential mechanisms for increased HIV-1 transmission across the endocervical epithelium during C. trachomatis infection. Curr HIV Res 2012; 10:218-227.
12. Sellati TJ, Wilkinson DA, Sheffield JS, et al. Virulent Treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1. J Infect Dis 2000; 181:283-293.
13. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophy-laxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363:2587-2599.
14. Juusola JL, Brandeau ML, Owens DK, et al. The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med 2012; 156:541-550.
15. Kessler J, Myers JE, Nucifora KA, et al. Evaluating the impact of prioritization of antiretroviral pre-exposure prophylaxis in New York City. AIDS 2014.
16. Paltiel AD, Freedberg KA, Scott CA, et al. HIV preexposure prophylaxis in the United States: Impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis 2009; 48(6):806-815.
17. Schneider K, Gray RT, Wilson DP. A cost-effectiveness analysis of HIV preexposure prophylaxis for men who have sex with men in Australia. Clin Infect Dis 2014; 58:1027-1034.
18. Desai K, Sansom SL, Ackers ML, et al. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness. AIDS 2008; 22:1829-1839.
19. Pathela P, Braunstein SL, Blank S, et al. HIV incidence among men with and those without sexually transmitted rectal infections: Estimates from matching against an HIV case registry. Clin Infect Dis 2013; 57: 1203-1209.
20. Bernstein KT, Marcus JL, Nieri G, et al. Rectal gonorrhea and chla-mydia reinfection is associated with increased risk of HIV seroconver-sion. J Acquir Immune Defic Syndr 2010; 53:537-543.
21. Solomon MM, Mayer KH, Glidden DV, et al. Syphilis predicts HIV incidence among men and transgender women who have sex with men in a pre-exposure prophylaxis trial. Clin Infect Dis 2014; 59:1020-1026.
22. Kelley CF, Vaughan AS, Luisi N, et al. The effect of high rates of bacterial sexually transmitted infections on hiv incidence in a cohort of black and white men who have sex with men in Atlanta, Georgia. AIDS Res Hum Retroviruses 2015; 31:587-592.
23. Menza TW, Hughes JP, Celum CL, et al. Prediction of HIV acquisition among men who have sex with men. Sex Transm Dis 2009; 36:547-555.
24. Purcell DW, Johnson CH, Lansky A, et al. Estimating the population size of men who have sex with men in the United States to obtain HIV and syphilis rates. Open AIDS J 2012; 6:98-107.
25. Zulman DM, Vijan S, Omenn GS, et al. The relative merits of population-based and targeted prevention strategies. Milbank Q 2008; 86:557-580.
26. Varghese B, Maher JE, Peterman TA, et al. Reducing the risk of sexual HIV transmission: Quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002; 29:38-43.
27. Baggaley RF, White RG, Boily MC. HIV transmission risk through anal intercourse: Systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol 2010; 39:1048-1063.
28. Vittinghoff E, Douglas J, Judson F, et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150:306-311.
29. Garcia-Garcia L, Gonzalez-Escalada JR, Ariza-Megia MC, et al. Syphilis: An epidemiological review. Curr Womens Health Rev 2012; 8:231-241.
30. Koppenhaver RT, Sorensen SW, Farnham PG, et al. The cost-effectiveness of pre-exposure prophylaxis in men who have sex with men in the United States: An epidemic model. J Acquir Immune Defic Syndr 2011; 58:e51-e52.
31. Buchbinder SP, Glidden DV, Liu AY, et al. HIV pre-exposure prophylaxis in men who have sex with men and transgender women: A secondary analysis of a phase 3 randomised controlled efficacy trial. Lancet Infect Dis 2014; 14:468-475.